Please assess the completion status of the following clinical trial:

Trial Title: Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Undergoing laparoscopic hysterectomy with or without salpingoophorectomy for benign indications~* Undergoing laparoscopic hysterectomy with robotic assistance with or without salpingoophorectomy for benign indications~* Between 18 and 60 years of age~Exclusion Criteria:~* Intraoperative detection of malignancy~* Undergoing additional procedures at the time of surgery (except prophylactic McCall culdoplasty/uterosacral ligament suspension, excision of endometriosis, appendectomy, cystoscopy)~* Inability to perform paracervical block due to anatomic abnormalities (absent/flush cervix)~* Known allergy/sensitivity to bupivacaine~* Intraoperative bowel injury, bladder injury, ureter injury or major vessel injury that required repair.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Control Group (Type: PLACEBO_COMPARATOR): Injection of 10 mL of 0.9% sodium chloride into the cervical stroma divided between 3 and 9 o'clock
- Study Group (Type: ACTIVE_COMPARATOR): Injection of 10 mL of 0.5% bupivacaine into the cervical stroma divided between 3 and 9 o'clock.

Based on this trial design, predict the completion outcome and termination type (if applicable).